• Lethal arenavirus infection is associated with severe hemorrhagic signs.

  • Primary and secondary hemostasis and vascular integrity are impaired.

Viral hemorrhagic fevers (HF) are a group of acute febrile diseases with high mortality rates. Although hemostatic dysfunction appears to be a major determinant of the severity of the disease, it is still unclear what pathogenic mechanisms lead to it. In clinical studies it is found that arenaviruses, such as Lassa, Machupo, and Guanarito viruses cause HF that vary in symptoms and biological alterations. In this study we aimed to characterize the hemostatic dysfunction induced by arenaviral HF to determine its implication in the severity of the disease and to elucidate the origin of this syndrome. We found that lethal infection with Machupo, Guanarito, and Lassa viruses is associated with cutaneomucosal, cerebral, digestive, and pulmonary hemorrhages. The affected animals developed a severe alteration of the coagulation system, which was concomitant with acute hepatitis, minor deficit of hepatic factor synthesis, presence of a plasmatic inhibitor of coagulation, and dysfunction of the fibrinolytic system. Despite signs of increased vascular permeability, endothelial cell infection was not a determinant factor of the hemorrhagic syndrome. There were also alterations of the primary hemostasis during lethal infection, with moderate to severe thrombocytopenia and platelet dysfunction. Finally, we show that lethal infection is accompanied by a reduced hematopoietic potential of the bone marrow. This study provides an unprecedented characterization of the hemostasis defects induced by several highly pathogenic arenaviruses.

1.
Carey
DE
,
Kemp
GE
,
White
HA
, et al
.
Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria
.
Trans R Soc Trop Med Hyg
.
1972
;
66
(
3
):
402
-
408
.
2.
Monath
TP
,
Mertens
PE
,
Patton
R
, et al
.
A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972
.
Am J Trop Med Hyg
.
1973
;
22
(
6
):
773
-
779
.
3.
Bowen
GS
,
Tomori
O
,
Wulff
H
,
Casals
J
,
Noonan
A
,
Downs
WG
.
Lassa fever in Onitsha, East Central State, Nigeria in 1974
.
Bull World Health Organ
.
1975
;
52
(
4-6
):
599
-
604
.
4.
Cheng
HY
,
French
CE
,
Salam
AP
, et al
.
Lack of evidence for ribavirin treatment of Lassa fever in systematic review of published and unpublished studies1
.
Emerg Infect Dis
.
2022
;
28
(
8
):
1559
-
1568
.
5.
Baillet
N
,
Reynard
S
,
Perthame
E
, et al
.
Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques
.
Commun Biol
.
2021
;
4
(
1
):
27
.
6.
Reynard
S
,
Carnec
X
,
Picard
C
, et al
.
The MOPEVAC vaccine induces humoral responses and sterilizing immunity against new world arenaviruses
.
Nat Microbiol
.
2023
;
8
(
1
):
64
-
76
.
7.
Hensley
L
,
Smith
M
,
Geisbert
J
, et al
.
Pathogenesis of Lassa fever in cynomolgus macaques
.
Virol J
.
2011
;
8
:
205
.
8.
McCormick
JB
,
King
IJ
,
Webb
PA
, et al
.
A case-control study of the clinical diagnosis and course of Lassa fever
.
J Infect Dis
.
1987
;
155
(
3
):
445
-
455
.
9.
Horton
LE
,
Cross
RW
,
Hartnett
JN
, et al
.
Endotheliopathy and platelet dysfunction as hallmarks of fatal Lassa fever
.
Emerg Infect Dis
.
2020
;
26
(
11
):
2625
-
2637
.
10.
Fisher-Hoch
SP
,
McCormick
JB
,
Sasso
D
,
Craven
RB
.
Hematologic dysfunction in Lassa fever
.
J Med Virol
.
1988
;
26
(
2
):
127
-
135
.
11.
Cummins
D
,
Fisher-Hoch
SP
,
Walshe
KJ
, et al
.
A plasma inhibitor of platelet aggregation in patients with Lassa fever
.
Br J Haematol
.
1989
;
72
(
4
):
543
-
548
.
12.
Cummins
D
,
Molinas
FC
,
Lerer
G
,
Maiztegui
JI
,
Faint
R
,
Machin
SJ
.
A plasma inhibitor of platelet aggregation in patients with argentine hemorrhagic fever
.
Am J Trop Med Hyg
.
1990
;
42
(
5
):
470
-
475
.
13.
Scott
SK
,
Hickman
RL
,
Lang
CM
,
Eddy
GA
,
Hilmas
DE
,
Spertzel
RO
.
Studies of the coagulation system and blood pressure during experimental Bolivian hemorrhagic fever in Rhesus monkeys
.
Am J Trop Med Hyg
.
1978
;
27
(
6
):
1232
-
1239
.
14.
Molinas
FC
,
Giavedoni
E
,
Frigerio
MJ
,
Calello
MA
,
Barcat
JA
,
Weissenbacher
MC
.
Alteration of blood coagulation and complement system in neotropical primates infected with Junin virus
.
J Med Virol
.
1983
;
12
(
4
):
281
-
292
.
15.
Lange
JV
,
Mitchell
SW
,
McCormick
JB
,
Walker
DH
,
Evatt
BL
,
Ramsey
RR
.
Kinetic study of platelets and fibrinogen in Lassa virus-infected monkeys and early pathologic events in Mopeia virus-infected monkeys
.
Am J Trop Med Hyg
.
1985
;
34
(
5
):
999
-
1007
.
16.
Kunz
S
.
The role of the vascular endothelium in arenavirus haemorrhagic fevers
.
Thromb Haemost
.
2009
;
102
(
6
):
1024
-
1029
.
17.
Peters
CJ
,
Zaki
SR
.
Role of the endothelium in viral hemorrhagic fevers
.
Crit Care Med
.
2002
;
30
(
5 Suppl
):
S268
-
273
.
18.
Lukashevich
IS
,
Maryankova
R
,
Vladyko
AS
, et al
.
Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-α gene expression
.
J Med Virol
.
1999
;
59
(
4
):
552
-
560
.
19.
Andrews
BS
,
Theofilopoulos
AN
,
Peters
CJ
,
Loskutoff
DJ
,
Brandt
WE
,
Dixon
FJ
.
Replication of dengue and Junín viruses in cultured rabbit and human endothelial cells
.
Infect Immun
.
1978
;
20
(
3
):
776
-
781
.
20.
Gomez
RM
,
Pozner
RG
,
Lazzari
MA
, et al
.
Endothelial cell function alteration after Junín virus infection
.
Thromb Haemost
.
2003
;
90
(
2
):
326
-
333
.
21.
Brocato
RL
,
Voss
TG
.
Pichinde virus induces microvascular endothelial cell permeability through the production of nitric oxide
.
Virol J
.
2009
;
6
:
162
.
22.
Lander
HM
,
Grant
AM
,
Albrecht
T
,
Hill
T
,
Peters
CJ
.
Endothelial cell permeability and adherens junction disruption induced by Junín virus infection
.
Am J Trop Med Hyg
.
2014
;
90
(
6
):
993
-
1002
.
23.
Mateo
M
,
Reynard
S
,
Journeaux
A
, et al
.
A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains
.
Sci Transl Med
.
2021
;
13
(
597
):
eabf6348
.
24.
Mateo
M
,
Reynard
S
,
Carnec
X
, et al
.
Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot
.
Sci Transl Med
.
2019
;
11
(
512
):
eaaw3163
.
25.
Uthman
IW
,
Gharavi
AE
.
Viral infections and antiphospholipid antibodies
.
Semin Arthritis Rheum
.
2002
;
31
(
4
):
256
-
263
.
26.
Rivadeneyra
L
,
Pozner
RG
,
Meiss
R
,
Fondevila
C
,
Gómez
RM
,
Schattner
M
.
Poly (I:C) downregulates platelet production and function through type I interferon
.
Thromb Haemost
.
2015
;
114
(
5
):
982
-
993
.
27.
Horton
LE
,
Sullivan
BM
,
Garry
RF
, et al
.
Dysfunctional platelet aggregation in patients with acute Lassa fever
.
Open Forum Infect Dis
.
2017
;
4
(
suppl 1
):
S223
.
28.
de Manzione
N
,
Salas
RA
,
Paredes
H
, et al
.
Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases
.
Clin Infect Dis
.
1998
;
26
(
2
):
308
-
313
.
29.
Strampe
J
,
Asogun
DA
,
Speranza
E
, et al
.
Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study
.
Lancet Infect Dis
.
2021
;
21
(
6
):
876
-
886
.
30.
Molinas
FC
,
de Bracco
MM
,
Maiztegui
JI
.
Coagulation studies in Argentine hemorrhagic fever
.
J Infect Dis
.
1981
;
143
(
1
):
1
-
6
.
31.
Duvignaud
A
,
Jaspard
M
,
Etafo
IC
, et al
.
Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study
.
Lancet Glob Health
.
2021
;
9
(
4
):
e469
-
e478
.
32.
Branco
LM
,
Grove
JN
,
Moses
LM
, et al
.
Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects
.
Virol J
.
2010
;
7
:
306
.
33.
Branco
LM
,
Garry
RF
.
Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms
.
Virol J
.
2009
;
6
(
1
):
147
.
34.
Hunt
BJ
,
Jurd
KM
.
Endothelial cell activation
.
BMJ
.
1998
;
316
(
7141
):
1328
-
1329
.
35.
Pozner
RG
,
Ure
AE
,
Jaquenod de Giusti
C
, et al
.
Junín virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling
.
PLoS Pathog
.
2010
;
6
(
4
):
e1000847
.
36.
Aiolfi
R
,
Sitia
G
,
Iannacone
M
,
Brunetta
I
,
Guidotti
LG
,
Ruggeri
ZM
.
Arenaviral infection causes bleeding in mice due to reduced serotonin release from platelets
.
Sci Signal
.
2022
;
15
(
722
):
eabb0384
.
37.
Levis
SC
,
Saavedra
MC
,
Ceccoli
C
, et al
.
Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever
.
J Interferon Res
.
1985
;
5
(
3
):
383
-
389
.
38.
Kornblith
LZ
,
Robles
AJ
,
Conroy
AS
,
Miyazawa
BY
,
Callcut
RA
,
Cohen
MJ
.
Tired platelet: functional anergy after injury
.
J Am Coll Surg
.
2017
;
225
(
4
):
S64
.
39.
Manukjan
G
,
Herrmann
J
,
Kleiß
J
, et al
.
Systemic platelet exhaustion in critically-ill Covid-19 patients [abstract]
.
Res Pract Thromb Haemost
.
2021
;
5
(
suppl 2
) Accessed 3 October 2023. https://abstracts.isth.org/abstract/systemic-platelet-exhaustion-in-critically-ill-covid-19-patients/.
40.
Fong
JS
,
Kaplan
BS
.
Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet “exhaustion”
.
Blood
.
1982
;
60
(
3
):
564
-
570
.
41.
Levi
M
,
van der Poll
T
.
Coagulation and sepsis
.
Thromb Res
.
2017
;
149
:
38
-
44
.
You do not currently have access to this content.
Sign in via your Institution